Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-11 Sale |
2024-03-11 5:24 pm |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
22,665 | $0 | $0 | 0 (Direct) |
View |
| 2023-04-12 Purchase |
2023-04-12 7:05 pm |
Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer |
4,000 | $25.37 | $101,479 | 259,500 (Direct) |
View |
| 2023-03-13 Purchase |
2023-03-13 4:06 pm |
Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer |
5,500 | $29.15 | $160,324 | 255,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-13 Option Award |
2024-11-13 5:46 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Myers Scott Dunseth Director |
260,192 | $0 | 260,192 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 8:32 pm |
N/A 2031-05-22 |
DYNAVAX TECHNOLOGIES CORP | DVAX | Myers Scott Dunseth Director |
27,857 | $0 | 47,946 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 4:30 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
2,048 | $0 | 22,666 (Direct) |
View |
| 2023-11-27 Option Award |
2023-11-28 4:26 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
5,000 | $0 | 20,618 (Direct) |
View |
| 2023-10-01 Option Award |
2023-10-02 5:36 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
5,797 | $0 | 15,618 (Direct) |
View |
| 2023-07-01 Option Award |
2023-07-06 6:34 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
35,634 | $0 | 98,215 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 4:36 pm |
N/A 2033-06-21 |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
46,000 | $0 | 46,000 (Direct) |
View |
| 2023-05-26 Option Award |
2023-05-31 5:35 pm |
N/A 2030-05-25 |
DYNAVAX TECHNOLOGIES CORP | DVAX | Myers Scott Dunseth Director |
27,857 | $0 | 42,589 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 5:06 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
34,925 | $0 | 62,581 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-07 6:55 pm |
N/A 2033-02-06 |
Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer |
1,250,000 | $0 | 1,250,000 (Direct) |
View |
| 2023-01-02 Option Award |
2023-01-04 5:06 pm |
N/A 2033-01-01 |
SELECTA BIOSCIENCES INC | SELB | Myers Scott Dunseth Director |
87,500 | $0 | 87,500 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 6:48 pm |
N/A 2032-06-21 |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
20,334 | $0 | 20,334 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 5:01 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | Myers Scott Dunseth Director |
20,893 | $0 | 20,893 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:34 pm |
N/A 2032-01-02 |
SELECTA BIOSCIENCES INC | SELB | Myers Scott Dunseth Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-10-25 Option Award |
2021-10-26 4:22 pm |
N/A 2031-10-25 |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
10,167 | $0 | 10,167 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-21 5:04 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | Myers Scott Dunseth Director |
55,714 | $0 | 55,714 (Direct) |
View |
Ownership |
2021-10-21 5:03 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | Myers Scott Dunseth Director |
0 | $0 | 0 (Direct) |
View |
| 2021-05-04 Option Award(A) |
2021-05-14 8:03 pm |
N/A 2031-05-03 |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
10,167 | $0 | 10,167 (Direct) |
View |
| 2021-05-04 Option Award |
2021-05-07 9:56 pm |
N/A 2031-05-03 |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
10,167 | $0 | 10,167 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 4:16 pm |
N/A 2031-05-03 |
Trillium Therapeutics Inc. | TRIL | Myers Scott Dunseth Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2021-03-30 Option Award |
2021-04-01 6:31 pm |
N/A 2031-03-29 |
SELECTA BIOSCIENCES INC | SELB | Myers Scott Dunseth Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2020-06-19 Option Award |
2020-06-23 4:47 pm |
N/A 2030-06-18 |
SELECTA BIOSCIENCES INC | SELB | Myers Scott Dunseth Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-05-28 Option Award |
2020-06-01 9:50 pm |
N/A 2030-05-27 |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
10,167 | $0 | 10,167 (Direct) |
View |
| 2020-04-28 Option Award |
2020-04-30 5:02 pm |
N/A 2030-04-28 |
AMAG PHARMACEUTICALS INC. | AMAG | Myers Scott Dunseth President & CEO |
1,000,000 | $0 | 1,000,000 (Direct) |
View |